Cart
sales@molnova.com
Home -
Products -
Antibody Drug Conjugates (ADC) -
ADCs Linker/Click Chemistry -
(Ac)Phe-Lys(Alloc)-PABC-PNP
(Ac)Phe-Lys(Alloc)-PABC-PNP
CAS No. ——
(Ac)Phe-Lys(Alloc)-PABC-PNP( —— )
Catalog No. M16946 CAS No. ——
A cathepsin cleavable ADC peptide linker.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(Ac)Phe-Lys(Alloc)-PABC-PNP
-
NoteResearch use only, not for human use.
-
Brief DescriptionA cathepsin cleavable ADC peptide linker.
-
DescriptionA cathepsin cleavable ADC peptide linker.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAntibody Drug Conjugates (ADC)
-
TargetADCs Linker/Click Chemistry
-
RecptorADCs Linker/Click Chemistry
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight689.7117
-
Molecular FormulaC35H39N5O10
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILES——
-
Chemical Nameallyl ((S)-5-((S)-2-acetamido-3-phenylpropanamido)-6-((4-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenyl)amino)-6-oxohexyl)carbamate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Shao LH, et al. Cancer. 2012 Jun 1;118(11):2986-96.
2. King HD, et al. J Med Chem. 2002 Sep 12;45(19):4336-43.
molnova catalog
related products
-
m-PEG8-NHS ester
m-PEG8-NHS ester is an 8-unit PEG-containing ADC linker that can be used to synthesize antibody-coupled reactive molecules (ADCs), which can be used to modify proteins and peptides.
-
Bz-(Me)Tz-NHS
Bz-(Me)Tz-NHS is a lipid compound containing a methyltetrazine moiety, known for its selectivity and utility in synthesizing a wide range of active molecules in biomedical research.
-
Hydroxy-PEG4-(CH2)2-...
Hydroxy-PEG4-(CH2)2-Boc is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG4-(CH2)2-Boc is extracted from patent WO2004008101A2 (compound 191).
